Deals
Reckitt Benckiser Would Look at Buying Pfizer Consumer Unit
- CEO Kapoor says he'd be `very interested' given opportunity
- Division would be good acquisition option, Exane analysts say
This article is for subscribers only.
Reckitt Benckiser Group Plc would consider acquiring Pfizer Inc.’s consumer-health unit were it to come up for sale in the wake of the Viagra maker’s merger with Allergan Plc.
Buying the unit would add the Advil, ChapStick and Centrum brands to a fast-growing portfolio of consumer-health products such as Nurofen painkillers and Durex condoms, Chief Executive Officer Rakesh Kapoor said Friday in an interview in London. The $160 billion Allergan deal may lead to Pfizer splitting up the enlarged organization, and the New York-based company has said it will decide on a potential separation by the end of 2018.